• In 2011, the company received the first samples of bacteriophage preparation against the pathogen Acinetobacter, which is the causative agent of a large number of hospital-acquired (nosocomial) infections and is resistant to antibiotics. (wikipedia.org)
  • An object of this invention is to provide a controlled release pharmaceutical preparation giving a so-called sigmoid type dissolution pattern wherein a lag time until the starting of the dissolution of a medicinal compound and the rate of the following dissolution can be controlled and the rate of the dissolution of the medicinal compound does not depend on the pH of a medium for the dissolution. (google.com.au)
  • and a method for treating or preventing a human nasal disease, which comprises administering a powdery preparation in unit dosage form to the nasal cavity of a human being requiring treatment or prevention of a nasal disease through his nostrils. (google.es)
  • 16. The powdery preparation of any one of claims 13 to 15 which is filled in a capsule. (google.es)
  • 19. The method of claim 18 wherein the administration of said powdery preparation to the nasal cavity is performed by spraying. (google.es)
  • This study covers the world outlook for antacid pharmaceutical preparations excluding effervescent salicylate analgesics across more than 190 countries. (marketresearch.com)
  • This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for antacid pharmaceutical preparations excluding effervescent salicylate analgesics. (marketresearch.com)
  • Phenyltoloxamine is widely used in preparations as an enhancing agent for some analgesics and antitussives (acetaminophen, dihydrocodeine, codeine, hydrocodone). (wikipedia.org)
  • It is projected that the revenue of manufacture of pharmaceutical preparations in Bulgaria will amount to approximately 502,9 million U.S. Dollars by 2023. (statista.com)
  • A sprayable pharmaceutical preparation available in doses in aerosol containers comprises an active ingredient dissolved in polyalkylene glycol, and/or polyethylene glycol, and/or fatty glycolic acid ester of glycerine-polyethylene such as glycerine-polyethyleneglycol oxyoleate and/or glycerine-polyethyleneglycol. (google.com.au)